29 articles for MS Malamas
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Novel triazines as potent and selective phosphodiesterase 10A inhibitors.

Pfizer
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors.

Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket.

Wyeth Research
Molecular modeling of the aldose reductase-inhibitor complex based on the X-ray crystal structure and studies with single-site-directed mutants.

National Eye Institute
Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.

Wyeth-Ayerst Research
Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.

Pfizer
New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region.

Pfizer
Design and synthesis of aminohydantoins as potent and selective humanß-secretase (BACE1) inhibitors with enhanced brain permeability.

Pfizer
Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors.

Biotie Therapies
Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitors.

Wyeth
Pyridinyl aminohydantoins as small molecule BACE1 inhibitors.

Wyeth Research
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.

Wyeth Research
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.

Wyeth Research
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.

Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.

Wyeth Research
Thiophene substituted acylguanidines as BACE1 inhibitors.

Wyeth Research
Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.

Wyeth Research
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Wyeth Research
Design and Structure-Activity Relationships of Isothiocyanates as Potent and Selective

Northeastern University
Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.

Northeastern University
Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.

Wyeth-Ayerst Research
New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.

Wyeth-Ayerst Research
Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Mak Scientific
Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.

Northeastern University
N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2.

Wyeth-Ayerst Research
Oximes short-acting CB1 receptor agonists.

Northeastern University
Quinazolineacetic acids and related analogues as aldose reductase inhibitors.

Wyeth-Ayerst Research
Isoxazole carboxamides as irreversible SMYD inhibitors

Epizyme
Inhibitors of lysine specific demethylase-1

Celgene Quanticel Research